Top Analysts Recommend 3 Best Stocks to Purchase Now, 11/20/2025
Top Stock Picks: Analysts have identified Nvidia, Astera Labs, and Capital One Financial as strong buy stocks, each receiving recent buy ratings and significant upside potential.
Nvidia (NVDA): The semiconductor company has seen positive market sentiment following strong Q3 results, with 36 out of 37 top analysts rating it a buy and a projected upside of about 30.85%.
Astera Labs (ALAB): This company specializes in chips for AI data centers, with 11 out of 13 top analysts giving it a buy rating and a projected upside of approximately 47.24%.
Capital One Financial (COF): The major U.S. bank has a buy rating from 10 out of 13 top analysts, with an increased price target suggesting an upside of about 28.15%.
Trade with 70% Backtested Accuracy
Analyst Views on ALAB
About ALAB
About the author
Astera Labs (ALAB.US) Insider Plans to Sell $4.37 Million in Common Stock via Form 144
Stock Sale Announcement: Aster Labs plans to sell 24,998 shares of its common stock on April 17.
Market Value: The total market value of the shares being sold is approximately $4.37 million.
Astera Labs (ALAB.US) Insider Plans to Sell $70.46 Million in Common Stock via Form 144
Share Sale Announcement: Jitendra Mohan intends to sell 412.5K shares of Astera Labs on April 17, with a total market value of approximately $70.46 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 379.19K shares, valued at around $51.52 million.
Astera Labs (ALAB.US) Insider Plans to Sell $35.19 Million in Common Stock via Form 144
Stock Sale Announcement: Jitendra Mohan plans to sell 206.25K shares of Astera Labs on April 15, with a total market value of approximately $35.19 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 376.22K shares, valued at around $51 million.
Astera Labs Shares Surge 27.2% Amid Strong Earnings Expectations
- Stock Surge: Astera Labs' share price surged by 27.2% week-over-week, reflecting investor confidence in the company's anticipated strong first-quarter earnings, indicating robust market sentiment.
- Optimistic Financial Outlook: The company expects first-quarter revenues to grow by 78% to 86% year-over-year, reaching between $286 million and $297 million, significantly up from $159.4 million in the same period last year, showcasing strong market demand.
- Doubling EPS Expectations: GAAP diluted earnings per share are projected to at least double to a range of $0.36 to $0.38, compared to $0.18 in the same quarter last year, highlighting a substantial enhancement in the company's profitability.
- R&D Center Expansion: Astera Labs plans to establish an advanced R&D center in Israel to accelerate the development of next-generation high-bandwidth connectivity protocols while addressing memory bottlenecks in AI training and inference applications, further solidifying its leadership in technological innovation.
Global X Cybersecurity ETF Underperforms
- ETF Decline: The Global X Cybersecurity ETF (BUG) fell approximately 4.9% during Friday afternoon trading, reflecting market concerns about the cybersecurity sector, which could impact investor confidence and lead to capital outflows.
- Weak Individual Stocks: Within the ETF, shares of Akamai Technologies (AKAM) dropped about 11.2%, while Palo Alto Networks (PANW) fell approximately 9%, indicating a weakening market outlook for these companies that may affect their ability to raise funds.
- Market Reaction Analysis: This decline may be linked to overall market sentiment, as investors adopt a cautious stance towards the cybersecurity industry's prospects, potentially putting more pressure on related firms in the short term.
- Investor Focus: Despite the ETF's poor performance, investors should remain attentive to technological innovations and shifts in market demand within the cybersecurity sector, as these factors could present potential investment opportunities in the long run.
ASTERA LABS INC: TD COWEN LOWERS TARGET PRICE FROM $170 TO $140
Company Overview: Aster Labs is a company that has recently made headlines for its significant price adjustments.
Price Adjustment: The target price for Aster Labs has been cut from $170 to $140, indicating a notable decrease in market expectations.
Astera Labs (ALAB.US) Insider Plans to Sell $4.37 Million in Common Stock via Form 144
Stock Sale Announcement: Aster Labs plans to sell 24,998 shares of its common stock on April 17.
Market Value: The total market value of the shares being sold is approximately $4.37 million.
Astera Labs (ALAB.US) Insider Plans to Sell $70.46 Million in Common Stock via Form 144
Share Sale Announcement: Jitendra Mohan intends to sell 412.5K shares of Astera Labs on April 17, with a total market value of approximately $70.46 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 379.19K shares, valued at around $51.52 million.
Astera Labs (ALAB.US) Insider Plans to Sell $35.19 Million in Common Stock via Form 144
Stock Sale Announcement: Jitendra Mohan plans to sell 206.25K shares of Astera Labs on April 15, with a total market value of approximately $35.19 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 376.22K shares, valued at around $51 million.
Astera Labs Shares Surge 27.2% Amid Strong Earnings Expectations
- Stock Surge: Astera Labs' share price surged by 27.2% week-over-week, reflecting investor confidence in the company's anticipated strong first-quarter earnings, indicating robust market sentiment.
- Optimistic Financial Outlook: The company expects first-quarter revenues to grow by 78% to 86% year-over-year, reaching between $286 million and $297 million, significantly up from $159.4 million in the same period last year, showcasing strong market demand.
- Doubling EPS Expectations: GAAP diluted earnings per share are projected to at least double to a range of $0.36 to $0.38, compared to $0.18 in the same quarter last year, highlighting a substantial enhancement in the company's profitability.
- R&D Center Expansion: Astera Labs plans to establish an advanced R&D center in Israel to accelerate the development of next-generation high-bandwidth connectivity protocols while addressing memory bottlenecks in AI training and inference applications, further solidifying its leadership in technological innovation.
Global X Cybersecurity ETF Underperforms
- ETF Decline: The Global X Cybersecurity ETF (BUG) fell approximately 4.9% during Friday afternoon trading, reflecting market concerns about the cybersecurity sector, which could impact investor confidence and lead to capital outflows.
- Weak Individual Stocks: Within the ETF, shares of Akamai Technologies (AKAM) dropped about 11.2%, while Palo Alto Networks (PANW) fell approximately 9%, indicating a weakening market outlook for these companies that may affect their ability to raise funds.
- Market Reaction Analysis: This decline may be linked to overall market sentiment, as investors adopt a cautious stance towards the cybersecurity industry's prospects, potentially putting more pressure on related firms in the short term.
- Investor Focus: Despite the ETF's poor performance, investors should remain attentive to technological innovations and shifts in market demand within the cybersecurity sector, as these factors could present potential investment opportunities in the long run.
ASTERA LABS INC: TD COWEN LOWERS TARGET PRICE FROM $170 TO $140
Company Overview: Aster Labs is a company that has recently made headlines for its significant price adjustments.
Price Adjustment: The target price for Aster Labs has been cut from $170 to $140, indicating a notable decrease in market expectations.
